{"id":28347,"date":"2014-08-14T09:57:20","date_gmt":"2014-08-14T13:57:20","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=28347"},"modified":"2014-08-14T09:57:20","modified_gmt":"2014-08-14T13:57:20","slug":"horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347","title":{"rendered":"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/14\/2014 (wallstreetpr) \u2013<strong>\u00a0<\/strong><strong>Horizon Pharma Inc (NASDAQ:HZNP)<\/strong> has announced that POZEN Inc. (NASDAQ:POZN) has got the notice of <a href=\"http:\/\/money.cnn.com\/news\/newsfeeds\/articles\/marketwire\/1137256.htm\">allowance<\/a> from the US Patent and Trademark Office. It is related with the patent application number 14\/045,156. It is under the title &#8220;Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs&#8221; The notice of allowance is related with VIMOVO\u00ae delayed release tablets. It is the US approved product of POZEN and Horizon.<\/p>\n<p style=\"text-align: justify;\"><strong>The notice<\/strong><\/p>\n<p style=\"text-align: justify;\">The Notice of Allowance includes the claims that state the expansion of the strength of its VIMOVO patent estate. It provides Horizon with the power to protect VIMOVO innovation. It is a significant form of therapy treatment for patients. \u00a0It ends the meaningful review of the patent application. Once the administrative processes get over, the company can get the issuance of US patent. It will be valid till 2022. \u00a0Horizon Pharma Inc (NASDAQ:HZNP) further aims to list the US patent in the Orange Book.<\/p>\n<p style=\"text-align: justify;\"><strong>The earnings beat<\/strong><\/p>\n<p style=\"text-align: justify;\">Horizon Pharma Inc (NASDAQ:HZNP)\u00a0also reported the strong results in the last week. The revenues saw a sharp jump of 495% year-over-year. The revenues came at $66.1 million in second-quarter. It was ahead of the analysts\u2019 expectation of $60.2 million. Net Income came at $20.7 million. It accounts for earnings of $0.21 per share, beating the analysts\u2019 expectation of $0.135 per share.<\/p>\n<p style=\"text-align: justify;\"><strong>The major source of revenues<\/strong><\/p>\n<p style=\"text-align: justify;\">Any form of development in its products, VIMOVO, RAYOS and DUEXIS is significant for Horizon Pharma Inc (NASDAQ:HZNP). These three products form the major source of revenues for the company. VIMOVO is an arthritis pain reliever. It contributed $42.4 million of the sales in the second-quarter. The contribution of RAYOS and DUEXIS stands at $3.9 million and $17.8 million respectively. \u00a0Horizon has plans to add Actimmune in its product portfolio. It can add the same once it completes the acquisition of Vidara Therapeutics in this September.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/14\/2014 (wallstreetpr) \u2013\u00a0Horizon Pharma Inc (NASDAQ:HZNP) has announced that POZEN Inc. (NASDAQ:POZN) has got the notice of allowance from the US Patent and [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":28349,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[4906,4907],"stock_ticker":[],"class_list":["post-28347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-horizon-pharma-inc-nasdaqhznp","tag-nasdaqhznp","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/14\/2014 (wallstreetpr) \u2013\u00a0Horizon Pharma Inc (NASDAQ:HZNP) has announced that POZEN Inc. (NASDAQ:POZN) has got the notice of allowance from the US Patent and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-14T13:57:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"198\" \/>\n\t<meta property=\"og:image:height\" content=\"254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance\",\"datePublished\":\"2014-08-14T13:57:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347\"},\"wordCount\":315,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg\",\"keywords\":[\"Horizon Pharma Inc. (NASDAQ:HZNP)\",\"NASDAQ:HZNP\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347\",\"name\":\"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg\",\"datePublished\":\"2014-08-14T13:57:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg\",\"width\":198,\"height\":254},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347","og_locale":"en_US","og_type":"article","og_title":"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance - Wall Street PR","og_description":"Boston, MA 08\/14\/2014 (wallstreetpr) \u2013\u00a0Horizon Pharma Inc (NASDAQ:HZNP) has announced that POZEN Inc. (NASDAQ:POZN) has got the notice of allowance from the US Patent and [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-14T13:57:20+00:00","og_image":[{"width":198,"height":254,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance","datePublished":"2014-08-14T13:57:20+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347"},"wordCount":315,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg","keywords":["Horizon Pharma Inc. (NASDAQ:HZNP)","NASDAQ:HZNP"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347","url":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347","name":"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg","datePublished":"2014-08-14T13:57:20+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/Horizon-Pharma-Inc.jpg","width":198,"height":254},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/horizon-pharma-inc-nasdaqhznp-gets-the-notice-of-allowance-28347#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Horizon Pharma Inc (NASDAQ:HZNP) Gets The Notice Of Allowance"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=28347"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28347\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/28349"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=28347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=28347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=28347"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=28347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}